Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
-0.30%87.500.8%$487.20m
MDTMedtronic PLC
-0.52%100.810.6%$433.48m
TMOThermo Fisher Scientific Inc.
-1.34%289.801.0%$404.21m
ISRGIntuitive Surgical, Inc.
-1.46%528.812.4%$388.28m
BDXBecton, Dickinson and Company
-1.22%250.731.1%$260.62m
EWEdwards Lifesciences Corporation
0.64%194.311.2%$257.97m
ALGNAlign Technology, Inc.
-0.76%281.216.3%$250.36m
BSXBoston Scientific Corporation
-0.92%42.251.1%$245.12m
SYKStryker Corporation
-1.16%208.021.3%$221.85m
BAXBaxter International Inc.
0.04%83.111.7%$187.05m
ZBHZimmer Biomet Holdings, Inc.
-0.51%123.451.7%$150.49m
DXCMDexCom, Inc.
-0.53%152.588.3%$136.46m
WATWaters Corporation
-0.52%213.703.8%$125.56m
ABMDABIOMED, Inc.
-0.88%260.473.3%$103.95m
COOCooper Companies, Inc.
-0.08%331.632.2%$94.97m

Company Profile

Antares Pharma, Inc. engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection for subcutaneous use, and Sumatriptan Injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.